X4 Pharmaceuticals Inc. (XFOR)
NASDAQ: XFOR
· Real-Time Price · USD
2.84
-0.30 (-9.55%)
At close: Aug 15, 2025, 3:59 PM
2.80
-1.41%
After-hours: Aug 15, 2025, 07:54 PM EDT
X4 Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.97M | 28.81M | 1.43M | 560K | 563K | n/a | 3.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 326K | 4.72M | 302K | 227K | 268K | 62K | 62K | 502K | 516K | 512K | 501K | 494K | 500K | 499K | 494K | 491K | 487K | 420K |
Gross Profit | 1.65M | 24.09M | 1.13M | 333K | 295K | -62K | 3M | -502K | -516K | -512K | -501K | -494K | -500K | -499K | -494K | -491K | -487K | -420K |
Operating Income | -26.23M | -9.44M | -35.72M | -34.5M | 71.1M | -37.29M | -25.2M | -27.21M | -25.8M | -25.8M | -22.91M | -25.58M | -20.57M | -21.27M | -29.05M | -19.12M | -19M | -17.94M |
Interest Income | 665K | 1.02M | 1.27M | 1.87M | 1.56M | 1.07M | 1.45M | 1.39M | 914K | 835K | 198K | 14K | 4K | 3K | 3K | 2K | 3K | 2K |
Pretax Income | -25.7M | 316K | -39.56M | -36.68M | 90.85M | -51.75M | -19.1M | -2.28M | -55.7M | -55.7M | -24.02M | -29.09M | -21.21M | -21.94M | -30.2M | -20.17M | -19.63M | -18.67M |
Net Income | -25.74M | 282K | -39.82M | -36.7M | 90.83M | -51.77M | -19.13M | -2.31M | -55.71M | -55.71M | -24.02M | -29.1M | -21.21M | -21.96M | -30.21M | -20.18M | -19.64M | -18.68M |
Selling & General & Admin | 9.53M | 15.02M | 15.14M | 15.66M | 13.28M | 17.43M | 9.93M | 8.13M | 10.2M | 10.2M | 7.24M | 6.56M | 6.75M | 7.66M | 7.13M | 5.93M | 5.8M | 5.83M |
Research & Development | 18.35M | 18.51M | 21.7M | 19.17M | 20.91M | 19.79M | 15.21M | 19.08M | 15.6M | 15.6M | 22.06M | 19.01M | 13.82M | 14.11M | 12.16M | 13.19M | 13.19M | 12.1M |
Other Expenses | n/a | n/a | n/a | n/a | -105M | n/a | n/a | n/a | -29.89M | -29.89M | 5.29M | -3.51M | -59K | 60K | -1.15M | -74K | -635K | 186K |
Operating Expenses | 27.88M | 33.53M | 36.85M | 34.83M | -70.81M | 37.23M | 25.14M | 27.21M | 25.8M | 25.8M | 29.3M | 25.58M | 20.57M | 21.78M | 19.3M | 19.12M | 19M | 17.94M |
Interest Expense | 2.23M | 2.2M | 2.3M | 2.41M | 2.18M | 1.87M | 1.89M | 1.63M | 1.15M | 1.11M | 1.14M | 1.02M | 918K | 913K | 925K | 920K | 905K | 891K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.17M | -7.85M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 28.2M | 38.25M | 37.15M | 35.06M | -70.54M | 37.29M | 25.2M | 27.21M | 25.8M | 25.8M | 29.3M | 25.58M | 20.57M | 21.78M | 19.3M | 19.12M | 19M | 17.94M |
Income Tax Expense | 37K | 34K | 258K | 15K | 18K | 19K | 33K | 26K | 15K | 15K | 4K | 14K | 4K | 23K | 3K | 2K | 6K | 6K |
Shares Outstanding (Basic) | 7.41M | 6.84M | 6.7M | 6.7M | 6.73M | 6.67M | 6.63M | 6.57M | 5.62M | 4.87M | 3.36M | 2.74M | 1.18M | 1.02M | 813.43K | 886.97K | 884.23K | 691.7K |
Shares Outstanding (Diluted) | 7.41M | 6.87M | 6.7M | 6.7M | 6.69M | 6.67M | 6.63M | 6.57M | 5.62M | 4.87M | 3.36M | 2.77M | 1.18M | 1.12M | 967.03K | 886.97K | 884.23K | 691.7K |
EPS (Basic) | -3.47 | 0.04 | -6 | -5.4 | 408.00 | -7.8 | -2.89 | -0.35 | -9.9 | -4.8 | -8.7 | -7.8 | -18 | -21.6 | -37.2 | -22.8 | -22.2 | -39 |
EPS (Diluted) | -3.47 | 0.04 | -6 | -5.4 | 405.00 | -7.8 | -2.89 | -0.35 | -9.9 | -4.8 | -8.7 | -7.8 | -18 | -21.6 | -37.2 | -22.8 | -22.2 | -39 |
EBITDA | -26.23M | 2.99M | -36.99M | -34M | -33.7M | -49.81M | -17.15M | -143K | -54.03M | -22.39M | -27.45M | -20.15M | -19.79M | -20.53M | -28.79M | -19.06M | -18.24M | -17.36M |
EBIT | -23.47M | 2.52M | -37.26M | -34.27M | -33.9M | -49.87M | -17.21M | -645K | -54.55M | -22.91M | -27.95M | -20.58M | -20.29M | -21.03M | -29.28M | -19.25M | -18.73M | -17.78M |
Depreciation & Amortization | n/a | 476K | 273K | 267K | 194K | 62K | 62K | 502K | 516K | 512K | 501K | 494K | 500K | 499K | 494K | 491K | 487K | 420K |